Crossmark

A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy

Crossref DOI link: https://doi.org/10.1016/j.ccell.2022.07.005

Published Print: 2022-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhang, Ziyang

Rohweder, Peter J. https://orcid.org/0000-0002-3194-689X
Ongpipattanakul, Chayanid

Basu, Koli

Bohn, Markus-Frederik

Dugan, Eli J.

Steri, Veronica

Hann, Byron

Shokat, Kevan M.

Craik, Charles S. https://orcid.org/0000-0001-7704-9185
Funding

Funding for this research was provided by:

Howard Hughes Medical Institute

Damon Runyon Cancer Research Foundation (DRG-2281-17)

Samuel Waxman Cancer Research Foundation

University of California

University of California, San Francisco

National Institutes of Health (T32 GM 064337)

Mark Foundation For Cancer Research
License Information

Text and Data Mining valid from 2022-09-01

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-08-04
More Information

This article is maintained by: Elsevier

Article Title: A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy

Journal Title: Cancer Cell

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2022.07.005

Content Type: article

Copyright: © 2022 The Authors. Published by Elsevier Inc.